Browse > Article
http://dx.doi.org/10.7732/kjpr.2017.30.6.601

Effects of the Jinan Red Ginseng Extract Treatment on Poloxamer 407-induced Hyperlipidemia in Rabbits  

Choi, Kyung-Min (Nakdonggang Institute of Biological Resources)
Lee, Jeong Ho (Sunchang Research Institute of Health and Longevity)
Adam, Gareeballah Osman (Department of Pharmacology, College of Veterinary Medicine, Chonbuk National University, Iksan Campus)
Kim, Shang-Jin (Department of Pharmacology, College of Veterinary Medicine, Chonbuk National University, Iksan Campus)
Kang, Hyung-Sub (Department of Pharmacology, College of Veterinary Medicine, Chonbuk National University, Iksan Campus)
Yang, Yeong-Seok (Division of Pharmaceutical Engineering, Woosuk University)
Kim, Gi-Beum (Korea Pickle Co., LTD.)
Publication Information
Korean Journal of Plant Resources / v.30, no.6, 2017 , pp. 601-611 More about this Journal
Abstract
Hyperlipidemia is an increase in one or more of the plasma lipids, including triglycerides, cholesterol. Ginseng has been used as a valuable tonic and for the treatment of various diseases. The objective of this study was to evaluate the effects of Jinan red ginseng (JRG) water extract on the blood and serum in rabbits with hyperlipidemia induced by poloxamer 407 when supplied in drinking water. JRG treatment was performed for 20 weeks. We evaluated the effects of the JRG treatment on diabetes through hematological and biochemical analysis before and after JRG treatment were performed. Our results indicate that LDL, total cholesterol, and triglycerides were significantly decreased compared prior JRG supply. CRE, BUN, CK and UA levels indicating renal functions are significantly reduced when compared to those prior to the JRG supply. In addition, AST, ALT, ALP, and LDH were significantly reduced indicating hepatoprotective effect. Blood electrolytes deteriorated in HL rabbits were improved when JRG supplied. In conclusion, Biochemical and hematological analysis demonstrate that the JRG is effective to alleviate the hyperlipidemia signs.
Keywords
High-density lipoprotein; Hyperlipidemia; Red Ginseng;
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
연도 인용수 순위
1 Bagdade, J., A. Casarettoand and J. Albers. 1976. Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man. J. Lab. Clin. Med. 87:38-48.
2 Baranov, A.I. 1982. Medicinal uses of ginseng and related plants in the Soviet Union: Recent trends in the soviet literature. J. Ethnopharmacol. 6:339-353.   DOI
3 Burtis, C.A. and E.R. Ashwood. 1994. Textbook of Clinical Chemistry. 2nd ed., Saunders Company, Philadelphia, USA. pp. 324-1327.
4 Chan, D.T., G.K. Dogra, A.B. Irish, E.M. Ooi, P.H. Barrett, D.C. Chan and G.F. Watts. 2009. Chronic kidney disease delays VLDL apoB-100 particle catabolism: potential role of apo C-III. J. Lipid Res. 50:2524-2531.   DOI
5 Chen, I.J., M.Y. Chang, S.L. Chiao, J.L. Chen, C.C. Yu, S.H. Yang, J.M. Liu, C.C. Hung. R.C. Yang, H.C. Chang, H.C. Hsu and J.T. Fang. 2012. KRG Improves Blood Pressure Stability in Patients with Intradialytic Hypotension. eCAM. 2012:595271.
6 Rahman, M.M., S.J. Lee, A.R. Mun, G.O. Adam, R.M. Park, G.B. Kim, H.S. Kang, J.S. Kim, S.J. Kim and S.Z. Kim. 2014. Relationships between blood $Mg^{2+}$ and energy metabolites/enzymes after acute exhaustive swimming exercise in rats. Biol. Trace. Element. Res. 161:85-90.   DOI
7 Rayssiguer, Y., L. Noe and J. Etienne. 1991. Effect of magnesium deficiency on post-heparin lipase activity and tissue lipoprotein lipase in the rats. Lipids 26:182-186.   DOI
8 Riggs, J. E. 2002. Neurologic manifestations of electrolyte disturbances. Neurol. Clin. 20:227-239.   DOI
9 Robles, N.R., J.M. Escola, L. Albarran and R. Espada. 1998. Correlation of serum magnesium and serum lipid levels in hemodialysis patients. Nephron 78:118-119.   DOI
10 Shimada, M., H. Shimano, T. Gotoda, K. Yamamoto, M. Kawamura, T. Inaba, Y. Yazaki and N. Yamada. 1993. Overexpression of human lipoprotein lipase in transgenic mice. J. Biul. Chem. 268:17924-17929.
11 Sohn, S.H., S.K. Kim, Y.O. Kim, H.D. Kim, Y.S. Shin, S.O. Yang, S.Y. Kim and S.W. Lee. 2013. A comparison of antioxidant activity of Korean white and red ginseng on $H_2O_2$-induced oxidative stress in HepG2 hepatoma cells. J. Ginseng Res. 37:442-450.   DOI
12 Sohn, E.H., T. Kim, Y.J. Jeong, H.S. Han, Y. Lea, Y.M. Cho and S.C. Kang. 2015. Triglyceride control effect of Agrimonia eupatoria L. in oleic acid induced NAFLD-HepG2 model. Korean J. Plant Res. 28(5):635-640.   DOI
13 Song, Y., T.Y. Li, R.M. Van Dam, J.E. Manson and F.B. Hu. 2007. Magnesium intake and plasma concentration of markers of systemic inflammation and endothelial dysfunction in women. Am. J. Clin. Nutr. 85:1068-1074.   DOI
14 Song, Y., P.M. Ridker, J.E. Manson, N.R. Cook and J.E. Buring. 2005. Liu. Magnesium intake, creative protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 28:1438-1444.   DOI
15 Cheung, A.K., C.J. Parker, K. Ren and P.H. Iverius. 1996. Increased lipase inhibition in uremia: identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma. Kidney Int. 49:1360-1371.   DOI
16 Chobanian, A.V. 1991. Single risk factor intervention may be inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolemia coexist. Hypertension 18:130-131.   DOI
17 Choi, K.T. 2008. 2008. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C. A. Meyer. Acta. Pharmacol. Sin. 29:1109-1118.   DOI
18 Corica, F., A. Corsonello, R. Ientile, D. Cucinotta, A. Di Benedtto, F, Perticone, L.J. Dominguez and M. Barbagallo. 2006. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J. Am. Coll. Nutr. 25:210-215.   DOI
19 Desai, S.D. and J. Blanchard. 1998. In vitro evaluation of Pluronic F127-based controlled-release ocular delivery systems for pilocarpine. J. Pharm. Sci. 87:226-230.   DOI
20 Dimeski, G., P. Mollee and A. Carter. 2006. Effects of hyperlipidemia on plasma sodium, potassium, and chloride measurements by an indirect ion-selective electrode measuring system. Clin. Chem. 52(1):155-156.   DOI
21 Ernst, E. 2010. Panax ginseng: an overview of the clinical evidence. JGR. 34:259-263.
22 Farias, R.A., M.F. Neto, G.S. Viana and V.S. Rao. 1996. Effects of Croton cajucara extract on serum lipids of rats fed a high fat diet. Phytother. Res. 10:697-699.   DOI
23 Gong, W.H., W.X. Zheng, J. Wang, S.H. Chen, B. Pangand and X.M. Hu, 2012. Coexistence of hyperlipidemia and acute cerebral ischemia/reperfusion induces severe liver damage in a rat model. World J. Gastroenterol. 18(35):4934-4943.   DOI
24 Spurzem, J.R., H.W. Bonekat and J.W. Shigeokaw. 1984. Factitious methemoglobinemia caused by hyperlipemia. Chest. 86:84-86.   DOI
25 Stratton, L.P., A. Dong, M.C. Manning and J.F. Carpenter. 1999. Drug delivery matrix containing native protein precipitates suspended in a polomaxamer gel. J. Pharm. Sci. 86:1006-l009.
26 Trent, C.M., S. Yu, Y. Hu, N. Skoller, L.A. Huggins, S. Homma and I.J. Goldberg. 2014. Lipoprotein lipase activity is required for cardiac lipid droplet production. J. Lipid Res. 55(4):645-658.   DOI
27 Vaziri, N.D. and K. Liang. 1996. Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. Kidney Int. 50:1928-1935.   DOI
28 Tsimihodimos, V., Z. Mitrogianni and M. Elisaf. 2011. Dyslipidemia associated with chronic kidney disease. Open Cardiovasc. Med. J. 5:41-48.   DOI
29 Vazquez-Perez, S., P. Aragoncillo, H.N. de Las, J. Navarro-Cid, E. Cediel, D. Sanz-Rosa, L.M. Ruilope, C. Diaz, G. Hernandez, V. Lahera and V. Cachofeiro. 2001. Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits. Nephrol. Dial. Transplant. 16:40-41.
30 Guerrero-Romero, F. and M. Rodriguez-Moran. 2000. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J. Diabetes Complications 14:272-276.   DOI
31 Guerrero-Romero, F. and M. Rodriguez-Moran. 2002. Low serum magnesium levels and metabolic syndrome. Acta. Diabetol. 39:209-213.   DOI
32 Hirano, T., T. Sakaue, A. Misaki, S. Murayama, T. Takahashi, K. Okada, H. Takeuchi, G. Yoshino and M. Adachi. 2003. Very low-density lipoproteinapoprotein CI is increased in diabetic nephropathy: comparison with apoprotein CIII. Kidney Int. 63:2171-2177.   DOI
33 Institute of Laboratory Animal Resources; Commission on Life Sciences; National Research Council. 1996. Guide for the Care and Use of Laboratory Animals. National Academy Press: Washington, DC (USA). pp. 1-124.
34 Jeyabalan, S. and M. Palayan. 2009. Antihyperlipidemic activity of Sapindus emarginatus in triton WR-1339 induced albino rats. Res. J. Pharm. Tech. 2(2):319-323.
35 Joan, M.B., B. Linda, C.F. Jon and J.R. Gary. 1999. Dose-dependent hyperlipidemia in rabbits following administration of poloxamer 407 gel. Pharmacology Letters Accelerated Communication. Life Sci. 65:261-266.
36 Wasan, K.M., R. Subramanian, M. Kwong, I.J. Goldberg, T. Wright and T.P. Johnston. 2003. Poloxamer 407-mediated alterations in the activities of enzymes regulating lipid metabolism in rats. J. Pharm. Pharm. Sci. 6(2):189-197.
37 Yokozawa, T., A. Ishida. E.J. Cho and T. Nakagawa. 2003. The effects of Coptidis Rhizoma extract on a hypercholesterolemic animal model. Phytomedicine. 10:17-22.   DOI
38 Yun, T.K. 2001. Brief introduction of Panax ginseng C.A. Meyer. J. Korean Med. Sci. 16:S3-S5 (in Korean).   DOI
39 Johnston, T.P. 2004. The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis: a review of findings to date. J. Cardiovasc. Pharmacol. 43:595-606.   DOI
40 Johnston, T.P. and W.K. Palmer. 1993. Mechanism of poloxamer 407-induced hypertriglyceridemia in the rat. Biochem. Pharmacol. 46:1037-1042.   DOI
41 Kim, Y.J., M.Y. Lee, Y.H. Son, B.K. Park, S.Y. Ryu and J.Y. Jung. 2014. Red ginseng ameliorates acute cisplatin-induced nephropathy. Planta. Med. 80:645-654.   DOI
42 Klionsky, D.J., H. Abeliovich, P. Agostinis, D.K. Agrawal, G. Aliev and D.S. Askew, et al. 2008. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4(2):151-175.   DOI
43 Larkin, B.G. and R.J. Zimmanck. 2015. Interpreting Arterial Blood Gases Successfully. AORN Journal 102:344-359
44 Lee, J.H. and C.S. Jeong. 2008. Inhibitory effects of ginsenoside Rb1, Rg3, and Panax ginseng head butanol fraction on inflammatory mediators from LPS-stimulated RAW 264.7 cells. Biomol. Therapeut. 16:277-285.   DOI
45 Lewington, S., G. Whitlock, R. Clarke, P. Sherliker, J. Emberson, J. Halsey, N. Qizilbash, R. Peto and R. Collins. 2007. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370:1829-1839   DOI
46 Michael, W.P. and K. Dermot. 1997. The effect of solubility and hyperlipidemia on perioperative arterial blood gas tensions. JCA. 9:331-333.
47 Min, S.W., S.H. Jung, K.H. Cho and D.H. Kim. 2008. Antihyperlipidemic effects of red ginseng, crataegii fructus and their main constituents ginsenoside Rg3 and ursolic acid in mice. Biomol. Therapeut. 16:364-369.   DOI
48 Mishra, P.R., P.K. Panda, K.C. Apanna and S. Panigrahi. 2011. Evaluation of acute hypolipidemic activity of different plant extracts in Triton WR-1339 induced in albino rats. Pharmacology online. 3:925-934.
49 Moberly, J.B., P.O. Attman, O. Samuelsson, A.C. Johansson, C. Knight- Gibson and P. Alaupovic. 1999. Apolipoprotein C-III, hypertriglyceridemia and triglyceride-rich lipoproteins in uremia. Miner. Electrolyte Metab. 25:258-262.   DOI
50 Nabavi, S.F., A. Sureda, S. Habtemariam and S.M. Nabavi. 2015. Ginsenoside Rd and ischemic stroke; a short review of literatures. J. Ginseng Res. 39:299-303.   DOI
51 Namama, T. 2015. Serum electrolytes and lipid profiles in non-insulin dependent diabetes mellitus patients. AJMS. 6:38-41.
52 Nerbrand, C., L. Agreus, R. A. Lenner, P. Nyberg and K. Svardsudd. 2003. The influence of calcium and magnesium in drinking water and diet on Cardio-vascular risk factors in individuals living in hard and soft water areas with differences in cardiovascular mortality. BMC Public Health 3:21-29.   DOI
53 Paolisso, G., S. Sgambato, G. Pezza, N. Passariello, M. Varricchio and F. D'Onofrio. 1989. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 12:265-269.   DOI
54 Park, T.Y. and J.Y. Cho. 2008. Inhibitory Effect of Ginsenoside-Rp1, a Novel Ginsenoside Derivative, on the Functional Activation of Macrophage-like Cells. Biomol. Therapeut. 16:370-376.   DOI
55 Park, J.D., D.K. Rhee and Y.H. Lee. 2005. Biological activities and chemistry of saponins from Panax ginseng C. A. Meyer. Photochemistry Reviews 4:159-175.   DOI
56 Park, K.H., S.J. Kim, J.Y. Kim, K.J. Min, J.R. Kim and K.H. Cho. 2017. Cold-water extract of KRG exhibits potent inhibitory effects against cholesteryl ester transfer protein activity and fructose-mediated glycation along with lipid-lowering activity in hyperlipidemic zebrafish. J. Ginseng Res. 1-12.
57 Park, T.Y., M.H. Park, W.C. Shin, M.H. Rhee, D.W. Seo, J.Y. Cho and H.M. Kim. 2008. Anti-metastatic potential of ginsenoside Rp1, a novel ginsenoside derivative. Biol. Pharm. Bull. 31:1802-1805.   DOI
58 Prinsen, B.H., M.G. de Sain-van der Velden, E.J. de Koning, H.A. Koomans, R. Berger and T.J. Rabelink. 2003. Hypertriglyceridemia in patients with chronic renal failure: possible mechanisms. Kidney Int. Suppl. 84:S121-S124.
59 Qi, L.W., C.Z. Wang and C.S. Yuan. 2011. Isolation and analysis of ginseng: advances and challenges. Natural Product Reports 28:467-495.   DOI